Signs of efficacy of new targeted agents and immunotherapies for multiple cancers
Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine. Despite medical research suffering setbacks ...
Sep 24, 2021
0
18